Middle East Healthcare Company

4009.SRSAUHealthcare● Active

$33.00

+$0.60(+1.85%)

Market Cap$3.0B

P/E Ratio—

52W High$60.7

52W Low$28.66

Avg Volume756K

Open$32.60

Beta-0.05

Cash on Hand Financials Revenue

Middle East Healthcare Company (4009.SR) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

4009.SR · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$26.3M▼ -49.7% vs prior year

FY · as of Dec 31, 2025 · Reported in SAR

Cash & Cash Equiv. (CCE)

$26.3M

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-49.7%

vs prior fiscal year

Latest Quarter

$24.1M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in SAR

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$26.3MCash on Hand

Total Debt$2.54BTotal Debt

Net Cash / Net Debt−$2.52BNet Debt Position

Cash vs Debt Ratio

Cash 1%Middle East Healthcare Company cash as % of market cap: 0.87%% · MCap $3BDebt 99%

Middle East Healthcare Company carries a net debt position of $2.52B. Total debt ($2.54B) exceeds cash on hand ($26.3M). Middle East Healthcare Company cash vs debt ratio: 1% cash / 99% debt.

Net Cash = Cash & ST Investments − Total Debt$26.3M − $2.54B = −$2.52B

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

4009.SR annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

4009.SR cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$26.3M-49.7%

Dec 31, 2024FY$52.3M+17.7%

Dec 31, 2023FY$44.4M+184.7%

Dec 31, 2022FY$15.6M-44.5%

Dec 31, 2021FY$28.1M+66.3%

4009.SR cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

4009.SR vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Middle East Healthcare CompanyYOU

4009.SR

$26.3M$3B0.9%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Middle East Healthcare Company (4009.SR) cash on hand as of December 31, 2025 is $26.3M, comprising $26.3M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Middle East Healthcare Company cash and short-term investments on the balance sheet (10-K filing). Also referred to as Middle East Healthcare Company cash reserves or cash position.

Middle East Healthcare Company annual cash on hand history shows decreased -49.7% in 2025: decreased -49.7% in 2025. Middle East Healthcare Company cash reserves in 2025 reflect the company's capital allocation strategy.

Middle East Healthcare Company carries total debt of $2.54B against cash of $26.3M, resulting in a net debt position of -$2.52B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

4009.SR cash on hand · 5 questions

As of December 31, 2025, Middle East Healthcare Company (4009.SR) has $26,301,483 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $26,301,483 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $24,097,188. Data sourced from the annual 10-K filing via FMP.

4009.SR cash on hand4009.SR cash reserves4009.SR cash 2025how much cash does 4009.SR have

▸ Source: FMP /balance-sheet-statement · US GAAP · Middle East Healthcare Company · Middle East Healthcare Company SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025